EMA announcement on possible radioactivity of medicinal products manufactured in Japan
2011.04.05
Active substance:
The BfArM calls attention to the public announcement made by the European Medicines Agency (EMA) in co-ordination with the European licensing authorities following the radiation leak from the Fukushima Daiichi nuclear power plant in Japan.